SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-035087
Filing Date
2022-12-09
Accepted
2022-12-09 20:19:41
Documents
1
Period of Report
2022-12-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7951
  Complete submission text file 0001493152-22-035087.txt   9461
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address
Riggs Josh (Reporting) CIK: 0001956391 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 221455985